Potent therapeutic efficacy of an alphavirus replicon DNA vaccine expressing human papilloma virus E6 and E7 antigens

Cervical cancer develops as a result of infection with high-risk human papillomavirus (HPV) through persistent expression of early proteins E6 and E7. Our group pioneered a recombinant viral vector system based on Semliki Forest virus (SFV) for vaccination against cervical cancer. The most striking...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncoimmunology
Auteurs principaux: van de Wall, Stephanie, Ljungberg, Karl, Ip, Peng Peng, Boerma, Annemarie, Knudsen, Maria L., Nijman, Hans W., Liljeström, Peter, Daemen, Toos
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis 2018
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6169581/
https://ncbi.nlm.nih.gov/pubmed/30288352
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1487913
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires